Olson, DE. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 563-567. 795 kB. https://doi.org/10.1021/acsptsci.0c00192 #Tabernanthalog
Cameron, LP; Tombari, RJ; Lu, J; Pell, AJ; Hurley, ZQ; Ehinger, Y; Olson, DE. A non-hallucinogenic psychedelic analogue with therapeutic potential Nature, 1 Jan 2021, 589 (7842), 474–479. 10.5 MB. https://doi.org/10.1038/s41586-020-3008-z #18 MS,NMR,IR
Cumming, P; Scheidegger, M; Dornbierer, D; Palner, M; Quednow, BB; Martin-Soelch, C. Molecular and functional imaging studies of psychedelic drug action in animals and humans Molecules, 1 Jan 2021, 26 (9), 2451. 3.5 MB. https://doi.org/10.3390/molecules26092451 #20
Duan, W; Cao, D; Wang, S; Cheng, J. Serotonin 2A receptor (5-HT2AR) agonists: Psychedelics and non-hallucinogenic analogues as emerging antidepressants Chem. Rev., 10 Jan 2024, 124 (1), 124–163. 12.6 MB. https://doi.org/10.1021/acs.chemrev.3c00375 #164